Avident Health’s MyNavigator Platform bridges the gap between clinical encounters and home care.
Nonadherence increases recurrence and death risk by 25–140%..
When patients are at home, away from the clinical setting, they face side effects, confusion, and anxiety. The adherence gap in oncology is a critical challenge that impacts survival rates and escalates costs.
of patients become nonadherent within six months of starting oral treatment
A HIPAA-compliant mobile application connecting clinical teams, patients, and Informal Cancer Caregivers (ICCs) for real-time support, symptom management, and oncology-specific care.
Direct communication and monitoring when it matters most.
Proactive tracking to manage side effects early.
Tailored specifically for the unique cancer care journey.
Designed to address the specific gaps in current oncology care models.
Currently, caregivers are often on the sidelines. We actively engage them as critical members of the care team.
Delivers the right information at the right time, matched to the patient's health literacy level.
Filters out the noise and alerts the clinical team only when specific thresholds are met.
Ensures that everyone from the oncologist to the family caregiver is aligned on the treatment plan.
Perspectives on cancer care navigation and treatment adherence from the Avident Health team.
Clinic and hospital leaders
The hormone pill starts the day she leaves the hospital. Leaders can set a home plan with the caregiver, see side effects early, and cut the calls that come back later.
For patients
The hormone pill is taken at home for years. A simple daily plan, help from a caregiver, and a clear way to reach your clinic can help you stay on track.
Physician leaders
The hormone pill starts the day she leaves. Physicians can set a clear home plan, include the caregiver, and stay involved without more pages.
